SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-069633
Filing Date
2020-03-11
Accepted
2020-03-11 07:30:33
Documents
6
Period of Report
2020-03-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d844577d8k.htm 8-K 25650
2 EX-10.1 d844577dex101.htm EX-10.1 5416
3 EX-10.2 d844577dex102.htm EX-10.2 32633
4 EX-99.1 d844577dex991.htm EX-99.1 12161
5 GRAPHIC g844577g0310204020924.jpg GRAPHIC 3266
6 GRAPHIC g844577g0311054354889.jpg GRAPHIC 3266
  Complete submission text file 0001193125-20-069633.txt   86411
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 20703891
SIC: 2834 Pharmaceutical Preparations